| scholarly article | Q13442814 |
| P2093 | author name string | W Patsch | |
| J D Morrisett | |||
| A R Sharrett | |||
| G Heiss | |||
| H A Tyroler | |||
| K Wu | |||
| P J Schreiner | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| LPA | Q18028636 | ||
| risk factor | Q1475848 | ||
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 826-33 | |
| P577 | publication date | 1993-06-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Lipoprotein[a] as a risk factor for preclinical atherosclerosis | |
| P478 | volume | 13 |
| Q35998449 | A Not-So-Little Role for Lipoprotein(a) in the Development of Calcific Aortic Valve Disease. |
| Q24315861 | Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice |
| Q35640331 | Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy |
| Q47272541 | Apolipoprotein(a) size polymorphism in young adults with ischemic stroke |
| Q34333272 | Cardiovascular risk factors in a Melanesian population apparently free from stroke and ischaemic heart disease: the Kitava study |
| Q35872497 | Carotid Intima-Media Thickness in Asymptomatic Subjects With Low Lipoprotein(a) Levels |
| Q64930565 | Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). |
| Q40984110 | Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy |
| Q37391667 | Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease |
| Q34186893 | Heart health in older adults. Import of heart disease and opportunities for maintaining cardiac health |
| Q42396853 | HyperLp(a)lipoproteinaemia: unmet need of diagnosis and treatment? |
| Q40579349 | Insulin and lipoprotein metabolism with special reference to the diabetic state |
| Q37961883 | Lipids and diabetic retinopathy |
| Q33944588 | Lipoprotein (a) and the risk of ischemic stroke in young women |
| Q30242031 | Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology |
| Q62273619 | Lipoprotein(A) in renal transplant recipients |
| Q74635708 | Lipoprotein(a) and coronary thrombosis and restenosis after stent placement |
| Q44518915 | Lipoprotein(a) and ultrasonographically determined early atherosclerotic changes in the carotid and femoral artery |
| Q77631965 | Lipoprotein(a) deposition is associated with the development of transplant renal arteriosclerosis in humans |
| Q41300659 | Lipoprotein(a) in health and disease |
| Q40937490 | Lipoprotein(a) in renal disease |
| Q77714432 | Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study |
| Q38297789 | Lipoprotein(a): searching for a function |
| Q64949790 | Maternal Cardiovascular Risk Assessment 3-to-11 Years Postpartum in Relation to Previous Occurrence of Pregnancy-Related Complications. |
| Q55020080 | Metabolic Pathway Genes Associated with Susceptibility Genes to Coronary Artery Disease. |
| Q27002774 | Niacin, an old drug with a new twist |
| Q42163578 | Nontraditional risk factors in carotid artery disease. |
| Q73245485 | Pentaerythritol tetranicotinate (niceritrol) decreases plasma lipoprotein(a) levels |
| Q35227434 | Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis |
| Q43813333 | Relationship of early carotid artery disease with lipoprotein (a), apolipoprotein B, and fibrinogen in asymptomatic essential hypertensive patients and normotensive subjects. |
| Q51587269 | Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness. |
| Q44465381 | Relationship of lipoprotein(a) with intimal medial thickness of the carotid artery in Type 2 diabetic patients in south India |
| Q50661669 | Serum distribution of lipoprotein(a) in African Americans and Nigerians: potential evidence for a genotype-environmental effect. |
| Q38670109 | Seventeen years of statin pharmacogenetics: a systematic review |
| Q33808934 | Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans |
| Q71802733 | The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis |
Search more.